why choose us

Clinical Trials Search

Showing 15,810 of 132,656 result(s)
Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice Clinicians

Status: Completed

Condition: Alzheimer's Disease and Related Dementias

Interventions: This study tests feasibility and acceptability of implementing a tool and training in a clinical practice and the preliminary efficacy of training mat

Date: 2023-01-20

Artificial Tears, Tear Lipids and Tear Film Dynamics

Status: Completed

Condition: Dry Eye

Interventions: 3 month use, 4 times daily, of Systane Complete PF, a lipid-based, preservative-free artificial tear product

Date: 2023-01-20

An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine

Status: Completed

Condition: Treatment-resistant Schizophrenia

Interventions: We will assess inflammatory;immune marker labs

Date: 2023-01-20

The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3)

Status: NOT_YET_RECRUITING

Condition: Sanfilippo Syndrome

Interventions:

Date: 2023-01-20

A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination;Control

Status: Completed

Condition: Respiratory Syncytial Virus Infections

Interventions: No intervention is administered in this extension study.
Participants received the RSVPreF3 vaccine during the prior RSV MAT studies (RSV MAT-001

Date: 2023-01-20

Nicotine Flux, a Potentially Powerful Tool for Regulating Nicotine Delivery From Electronic Cigarettes

Status: Completed

Condition: Nicotine Vaping

Interventions: Participants will receive the free-base form of four nicotine fluxes: 9, 18, 27, 35 ?g;sec at one of their two visits.
Participants will use

Date: 2023-01-20

An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Status: ACTIVE_NOT_RECRUITING

Condition: Chronic Kidney Disease

Interventions: Retrospective cohort analysis using United States Optum EHR data and OM1 RWDC databases.

Date: 2023-01-20

A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Status: Completed

Condition: Pulmonary Hypertension (World Health Organization Group 2)

Interventions: The participants will receive AZD3427 SC injection single dose of either Dose A or Dose B or Dose C every 2 weeks for 24 weeks.

Date: 2023-01-20

Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung

Status: NOT_YET_RECRUITING

Condition: Clinical Stage IV Cutaneous Melanoma AJCC v8

Interventions: Given via inhalation with nebulizer

Date: 2023-01-20

Effect of Exercise Among Turtle Neck Syndrome in Pakistani Patients

Status: Active, not recruiting

Condition: Neck Pain

Interventions: Interventional

Date: 2023-01-20